Doctor profile · Federal record
Dr. Stanley Nabrinsky, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Elgin, IL
- NPI 1568459774
- Accepts Medicare
- MIPS 66.3 / 100 · 2023
- 42 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1710 N Randall RD, Ste 300
Elgin, IL 601239400
(847) 931-0909
fax (847) 931-0939 - Mailing address
-
25070 Network Pl
Chicago, IL 606732150
Credentials & registration
- NPI registered
- October 2005 — 21 yrs on file
- Profile last updated
- December 17, 2021
- Year of graduation
- 1984 — 42 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Illinois #036089310
- Medicaid
- IL #036089310
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1568459774. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
148,892
Distinct HCPCS
10
Medicare allowed
$1,981,662
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 44,370 | 20 | $0 | |
J1756 |
Injection, iron sucrose, 1 mg | 23,600 | 25 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 19,600 | 14 | $54 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 14,100 | 14 | $3 | |
J1453 |
Injection, fosaprepitant, 1 mg | 11,400 | 22 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 9,600 | 17 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 5,134 | 63 | $0 | |
Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 3,920 | 16 | $8 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 2,400 | 43 | $1 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,988 | 414 | $8 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 3,038. This provider delivers 49× the peer median.Open Payments
Industry payments received
All-time total
$26,321
Transactions
130
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| EMD Serono, Inc. | 6 | $10,866.69 | |
| AstraZeneca Pharmaceuticals LP | 20 | $7,521.39 | |
| BeiGene USA, Inc. | 4 | $2,643.17 | |
| Novartis Pharmaceuticals Corporation | 29 | $1,430.28 | |
| Genentech USA, Inc. | 9 | $1,185.40 | |
| E.R. Squibb & Sons, L.L.C. | 7 | $295.89 | |
| PFIZER INC. | 14 | $279.26 | |
| ABBVIE INC. | 14 | $215.19 | |
| Lilly USA, LLC | 2 | $214.04 | |
| SOBI, INC | 1 | $200.00 | |
| Celgene Corporation | 7 | $158.57 | |
| Astellas Pharma US Inc | 5 | $141.17 | |
| Merck Sharp & Dohme LLC | 5 | $116.88 | |
| Gilead Sciences, Inc. | 4 | $90.32 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70.28 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
611
Patients
146
Total drug cost
$1,834,635
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Xarelto (Rivaroxaban) | Brand | 107 | 30 | $144,580 |
| Eliquis (Apixaban) | Brand | 92 | 24 | $80,194 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 44 | 0 | $832,686 |
| Warfarin Sodium | Generic | 42 | 14 | $752 |
| Dexamethasone | Generic | 40 | 21 | $767 |
| Hydroxyurea | Generic | 40 | 11 | $1,107 |
| Ondansetron Hcl | Generic | 39 | 33 | $1,280 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 38 | 0 | $3,147 |
| Prednisone | Generic | 33 | 13 | $306 |
| Tamoxifen Citrate | Generic | 27 | 0 | $1,418 |
Hospital affiliations
Frequently asked questions
What is Dr. Stanley Nabrinsky's medical specialty?
Dr. Stanley Nabrinsky practices Hematology & Oncology Physician in Elgin, IL.
Where does Dr. Stanley Nabrinsky practice?
Dr. Stanley Nabrinsky practices at 1710 N Randall RD, Elgin, IL 601239400. Office phone: 8479310909.
What is Dr. Stanley Nabrinsky's NPI?
Dr. Stanley Nabrinsky's National Provider Identifier (NPI) is 1568459774, issued by NPPES.
Does Dr. Stanley Nabrinsky accept Medicare assignment?
Yes. Dr. Stanley Nabrinsky accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Stanley Nabrinsky commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, iron sucrose, 1 mg (HCPCS J1756); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.